• No results found

Implementation of Fuzzy Logic Controller for PV Interfaced Grid Connected PBT Based DSTATCOM for Real and Reactive Power Control

N/A
N/A
Protected

Academic year: 2020

Share "Implementation of Fuzzy Logic Controller for PV Interfaced Grid Connected PBT Based DSTATCOM for Real and Reactive Power Control"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 2: The Schematic diagram of Fuzzy logic controlled PBT based DSTATCOM control algorithm for extracting reference source
Fig. 6: Membership functions considered for scaling output
Table-2: Active and reactive power comparisions of PBT based DSTATCOM with grid connected PV generation  system using PI & fuzzy logic controller for active and reactive power control
Fig 9(a-b): The Real power flow in the system with PV Interfaced grid connected PBT based PI controlled DSTATCOM

References

Related documents

Statistical tests for evidence of partial sweeps have been applied to genome-wide variation data in humans to detect candidate adaptive mutations currently sweeping through

Similarly, a study on Speaker recognition using Mel Frequency Cepstral Coefficients (MFCC) and Vector Quantization (VQ) Techniques [7] has also used hamming window technique..

ABSTRACT: In this paper we establish a theorem, using same technique in sieve of Eratosthenes, to find unknown prime numbers in a given range, also in the given

Since we are interested in the case of a small coefficient of variation (cv), we will use Stein's approximation method for the mean and standard deviation of the interspike

cerevisiae : The functional similarity of Rag4 and Snf3/Rgt2 was suggested by the impairment of transcription of glucose permease genes in the corre- sponding mutants: RAG1

Using these results, we solve the problem of robust stabilization with respect to normalized coprime factor perturbations for a class of innite-dimensional systems ( A; B; B.. ;

Effects of combinations of EMAP with sorafenib and gemcitabine were evaluated in ECs and fibroblast cells, and a significant additive effect on inhibition of cell proliferation

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea. Vannucchi AM,